Palatin Technologies Inc
Pharmaceutical company · Cranbury, New Jersey, United States · Nasdaq: PTN
Palatin Technologies Inc is a pharmaceutical company headquartered in Cranbury, New Jersey, United States. Its shares trade on Nasdaq under the ticker PTN. It has received 10 US government small-business research awards (SBIR/STTR) from health agencies, $1.7 million in total, most recently in 2001. It has reported private securities offerings to the US SEC, most recently $35 million sold in a notice filed in 2012.
Palatin Technologies at a glance
What does Palatin Technologies do?
US government research funding
10 SBIR/STTR small-business research awards from US health agencies, $1.7 million in total (1998 to 2001).
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $35 million sold (2012).
Frequently asked questions about Palatin Technologies
Where is Palatin Technologies headquartered?
Palatin Technologies Inc is headquartered in Cranbury, New Jersey, United States.
What does Palatin Technologies do?
Palatin Technologies Inc is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Palatin Technologies a public company?
Yes. Palatin Technologies Inc trades on Nasdaq under the ticker PTN.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.